Overview

Eptinezumab in Healthy Japanese Subjects

Status:
Completed

Trial end date:
2020-08-13

Target enrollment:

Participant gender:

Summary

The purpose of this study is to investigate how eptinezumab enters, moves through and exits the body. Safety and tolerability will also be investigated.

Phase:

Phase 1

Details

Lead Sponsor:

H. Lundbeck A/S